Insider Transactions in Q2 2024 at Allscripts Healthcare Solutions, Inc. (MDRX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 31
2024
|
Carol J Zierhoffer |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+33.29%
|
-
|
|
May 31
2024
|
Jonathan Judge |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+19.43%
|
-
|
|
May 31
2024
|
David B Stevens |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+36.11%
|
-
|
|
May 31
2024
|
Lisa Hammond SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
52,632
+30.51%
|
-
|
|
May 31
2024
|
Susan Rodriguez |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+50.0%
|
-
|
|
May 31
2024
|
Elizabeth Ann Altman |
BUY
Grant, award, or other acquisition
|
Direct |
42,106
+35.16%
|
-
|
|
May 31
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
157,895
+32.24%
|
-
|
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,179
-7.57%
|
$55,611
$9.5 P/Share
|
|
May 31
2024
|
Greg Garrison Execuitive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
21,053
+20.5%
|
-
|
|
May 31
2024
|
Leland Westerfield CFO |
BUY
Grant, award, or other acquisition
|
Direct |
105,264
+50.0%
|
-
|
|
May 31
2024
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
63,158
+16.39%
|
-
|
|
May 25
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-2.24%
|
$10,780
$7.55 P/Share
|
|
May 03
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,105
-2.97%
|
$14,735
$7.7 P/Share
|
|
May 03
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,169
-1.21%
|
$22,183
$7.7 P/Share
|
|
May 02
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,893
-1.08%
|
$13,251
$7.8 P/Share
|
|
May 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,354
-5.05%
|
$65,478
$7.82 P/Share
|
|
May 01
2024
|
Tejal Vakharia SVP General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,301
-1.61%
|
$30,107
$7.82 P/Share
|
|
Apr 01
2024
|
Lisa Hammond SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.27%
|
$1,351
$7.8 P/Share
|
|
Apr 01
2024
|
Thomas Langan CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,709
-1.51%
|
$39,963
$7.8 P/Share
|
|
Apr 01
2024
|
Thomas Langan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,304
+5.12%
|
-
|